Alan Lau

Title: Alan Lau - Innovator in Protein Therapeutics

Introduction

Alan Lau is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel protein compositions aimed at enhancing cancer treatment. His innovative work has led to the creation of a unique fusion protein that combines therapeutic antibodies with IL2 mutants.

Latest Patents

Alan Lau holds a patent for "Rationally designed protein compositions." This patent describes a novel composition and methods related to a rationally designed fusion protein that combines a therapeutic antibody with an IL2 mutant. This innovative fusion protein can enhance anti-tumor immunity while simultaneously derepressing tumor-associated immunosuppression. It also allows for the direct activation of effector cells by IL2 without activating T regulatory cells. The fusion protein has potential applications in preventing or therapeutically treating cancer.

Career Highlights

Throughout his career, Alan Lau has worked with various organizations, including 1Globe Biomedical Co., Ltd. and 1Globe Health Institute LLC. His experience in these companies has contributed to his expertise in the field of protein therapeutics and cancer treatment.

Collaborations

Alan has collaborated with notable professionals in his field, including Chiang Jia Li and Shyam Unniraman. These collaborations have further enriched his research and development efforts.

Conclusion

Alan Lau is a pioneering inventor whose work in rationally designed protein compositions holds promise for advancing cancer therapies. His innovative approach and collaborations continue to impact the field positively.